DMAC vs PGR · $157.4M cap vs P/E 10, rev $87.67B
DiaMedica Therapeutics Inc (DMAC) versus Progressive Corp (PGR) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Progressive Corp (PGR) is a insurance - property & casualty company listed on NYSE.
DMAC does not have a complete income-statement cache yet.
Latest reported PGR revenue for 2025-12-31 was $87.67B. Net income was $11.31B. Revenue was up 16.3% from 2024-12-31 to 2025-12-31. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
DMAC currently screens at market cap $157.4M. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
Not investment advice. Open the DMAC and PGR stock pages for the full models.
Not investment advice.